Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Children's National to Issue Consensus Paper on Pediatric Surgical Innovation and Device Development

August 29, 2013

Washington, DC—The Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Medical Center is facilitating an international consensus paper as an outcome of its International Symposium on Pediatric Surgical Innovation, held in June to discuss the current status and challenges to pediatric surgical innovation and medical device development. The symposium included discussions such as strategies for seeking regulatory approval in the top three medical device markets – the United States, the European Union, and Japan.

Following the day-long symposium, the organizers held a closed session with key opinion leaders and speakers from the conference to begin the formation of the white paper, which will be published in the last quarter of 2013. This document will outline a consensus from world-renowned thought leaders on recommended priorities and changes to address current challenges and to speed advances in pediatric surgical innovation and device development.  The white paper will address the unique nature of innovation in pediatric surgery and device development, current regulatory pathways, economic models, ethical concerns specific to medical product development for the pediatric population, the impact of regulatory standards worldwide, and best practices that might be shared across different regions of the globe.

“Calls are growing, from around the world, for change that will spur innovation in surgery and medical device development for pediatrics,” said Peter Kim, MD CM, PhD, Vice President of the Sheikh Zayed Institute for Pediatric Surgical Innovation. “This white paper will provide a consensus, from leaders across the many disciplines involved, on priorities and steps to address the clinical, technical, economic and regulatory requirements that can hinder progress, if not addressed strategically.”

Topics the white paper will address include the FDA’s 510(k) clearance process, which applies to most pediatric medical devices, based largely on equivalence to existing devices created for adults. The white paper will also discuss factors related to the small size and vulnerable nature of the pediatric population, which presents distinct challenges for surgeons, researchers, manufacturers, and regulators in device development for this population.

“We know that infants and children are not simply small adults—their physiology is different, and they experience rapid anatomical and physiological change,” said Mark Batshaw, MD, Executive Vice President, Chief Academic Officer, and Physician-in-Chief at Children’s National. “An improved regulatory framework for pediatric devices and surgical tools will reflect these substantial differences, keeping safety paramount while encouraging future innovation and investment.”

The Sheikh Zayed Institute symposium drew nearly 250 high-level participants, including representatives from the U.S. Food and Drug Administration, European Medicines Agency, Japan’s Pharmaceuticals and Medical Devices Agency, U.S. National Institutes of Health, American Academy of Pediatrics, American Pediatric Surgical Association, World Federation of Associations of Pediatric Surgeons, children’s hospitals, pediatric device consortia, device makers, and experts in intellectual property and regulatory science. Video highlights from the symposium are available here: YouTube.

Contact: Leah Parker or Paula Darte, 202-476-4500.

About Children's National Health System

Children’s National Health System, based in Washington, D.C., has served the nation’s children since 1870. Children’s National is one of the nation’s Top 5 pediatric hospitals and, for a second straight year, is ranked No. 1 in newborn care, as well as ranked in all specialties evaluated by U.S. News & World Report. It has been designated two times as a Magnet® hospital, a designation given to hospitals that demonstrate the highest standards of nursing and patient care delivery. This pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers in the D.C. Metropolitan area, including the Maryland suburbs and Northern Virginia. Home to the Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National is the seventh-highest NIH-funded pediatric institution in the nation. Children’s National is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels. 

For more information, follow us on Facebook and Twitter.